Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

Brian Green; P.R. Flatt; K. Lavery; N. Irwin; F.P.M. O'Harte; Patrick Harriott; Brett Greer; C.J. Bailey

doi:10.1124/jpet.105.097824

Novel glucagon-like peptide-1 (GLP-1) analog (Val⁸)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

Brian Green
, P.R. Flatt
, K. Lavery
, N. Irwin
, F.P.M. O'Harte
, Patrick Harriott
, Brett Greer
, C.J. Bailey

School of Biological Sciences

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

Original language	English
Pages (from-to)	914-921
Number of pages	8
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	318(2)
Issue number	2
DOIs	https://doi.org/10.1124/jpet.105.097824
Publication status	Published - Apr 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1124/jpet.105.097824

Cite this

Green, B., Flatt, P. R., Lavery, K., Irwin, N., O'Harte, F. P. M., Harriott, P., Greer, B., & Bailey, C. J. (2006). Novel glucagon-like peptide-1 (GLP-1) analog (Val⁸)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice. Journal of Pharmacology and Experimental Therapeutics, 318(2)(2), 914-921. https://doi.org/10.1124/jpet.105.097824

@article{c261aa8360724ab09aa69891420fcbc8,

title = "Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.",

author = "Brian Green and P.R. Flatt and K. Lavery and N. Irwin and F.P.M. O'Harte and Patrick Harriott and Brett Greer and C.J. Bailey",

year = "2006",

month = apr,

doi = "10.1124/jpet.105.097824",

language = "English",

volume = "318(2)",

pages = "914--921",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "Elsevier Inc.",

number = "2",

}

Green, B, Flatt, PR, Lavery, K, Irwin, N, O'Harte, FPM, Harriott, P, Greer, B & Bailey, CJ 2006, 'Novel glucagon-like peptide-1 (GLP-1) analog (Val⁸)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.', Journal of Pharmacology and Experimental Therapeutics, vol. 318(2), no. 2, pp. 914-921. https://doi.org/10.1124/jpet.105.097824

Novel glucagon-like peptide-1 (GLP-1) analog (Val⁸)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice. / Green, Brian; Flatt, P.R.; Lavery, K. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 318(2), No. 2, 04.2006, p. 914-921.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

AU - Green, Brian

AU - Flatt, P.R.

AU - Lavery, K.

AU - Irwin, N.

AU - O'Harte, F.P.M.

AU - Harriott, Patrick

AU - Greer, Brett

AU - Bailey, C.J.

PY - 2006/4

Y1 - 2006/4

UR - https://www.scopus.com/pages/publications/33745937115

U2 - 10.1124/jpet.105.097824

DO - 10.1124/jpet.105.097824

M3 - Article

C2 - 16648370

SN - 0022-3565

VL - 318(2)

SP - 914

EP - 921

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 2

ER -